Tags

Type your tag names separated by a space and hit enter

Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study.
Climacteric. 2020; 23(sup1):S24-S27.C

Abstract

The aim of this multicentric, prospective study was to evaluate the effects of vaginal erbium laser (VEL-SMOOTH®) on sexual function in postmenopausal women suffering from the genitourinary syndrome of menopause (GSM). This study was performed on an outpatient basis without anesthesia or drug use before or after the intervention, using an erbium laser (XS Fotona Smooth®, Fotona, Ljubljana, Slovenia) in 1081 postmenopausal women (age 54.3 ± 3.9 years) treated with up to three laser applications every 30 days. Patients were assessed using the Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale-Revised (FSDS-R). No adverse events were recorded during the study. The FSDS-R scores (n = 554), from basal values of 25.5 ± 3.5, were 11.5 ± 3.0, 10.5 ± 3.5 and 11.5 ± 3.5 at the 4-, 12- and 24-week follow-ups, respectively (p < 0.01 vs. corresponding basal values). Individual FSFI domain scores (n = 569) significantly (p < 0.001) increased after VEL-SMOOTH® treatment and remained significantly higher up to the 24th week after the end of treatment. The total scores, from basal values of 15.5 ± 1.5, were 27.5 ± 2.5, 27.6 ± 2.7and 27.0 ± 3.5 at the 4-, 12- and 24-week follow-ups, respectively (p < 0.01 vs. corresponding basal values). Albeit not randomized, this large, prospective study shows that VEL-SMOOTH® treatment may improve sexual function in postmenopausal women suffering from GSM.

Authors+Show Affiliations

Department of Obstetrics and Gynecology, University Hospital, Pisa, Italy.Gynecological Clinic Elysium, Albignasego (Padova), Italy.Centro Palmer, Reggio Emilia, Italy.Ospedale Campo di Marte, Lucca, Italy.Studio Medico, Novara, Italy.Centro Medico Radiologico 3P, Noventa di Piave, Italy.Department of Obstetrics and Gynecology, University of Perugia, Italy.Centro Mediprò Bologna, Italy.Centro Medico Demetra, Grottaferrata, Italy.Clinica Paideia, Rome, Italy.No affiliation info available

Pub Type(s)

Journal Article
Multicenter Study

Language

eng

PubMed ID

33124454

Citation

Gambacciani, M, et al. "Sexual Function After Vaginal Erbium Laser: the Results of a Large, Multicentric, Prospective Study." Climacteric : the Journal of the International Menopause Society, vol. 23, no. sup1, 2020, pp. S24-S27.
Gambacciani M, Albertin E, Torelli MG, et al. Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study. Climacteric. 2020;23(sup1):S24-S27.
Gambacciani, M., Albertin, E., Torelli, M. G., Bracco, G. L., Casagrande, A. C., Martella, L., Baiocchi, G., Alfieri, S., Russo, N., & Cervigni, M. (2020). Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study. Climacteric : the Journal of the International Menopause Society, 23(sup1), S24-S27. https://doi.org/10.1080/13697137.2020.1804544
Gambacciani M, et al. Sexual Function After Vaginal Erbium Laser: the Results of a Large, Multicentric, Prospective Study. Climacteric. 2020;23(sup1):S24-S27. PubMed PMID: 33124454.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study. AU - Gambacciani,M, AU - Albertin,E, AU - Torelli,M G, AU - Bracco,G L, AU - Casagrande,A C, AU - Martella,L, AU - Baiocchi,G, AU - Alfieri,S, AU - Russo,N, AU - Cervigni,M, AU - ,, PY - 2020/10/30/entrez PY - 2020/10/31/pubmed PY - 2021/7/9/medline KW - Menopause KW - genitourinary syndrome of menopause KW - sexual function KW - vaginal erbium laser SP - S24 EP - S27 JF - Climacteric : the journal of the International Menopause Society JO - Climacteric VL - 23 IS - sup1 N2 - The aim of this multicentric, prospective study was to evaluate the effects of vaginal erbium laser (VEL-SMOOTH®) on sexual function in postmenopausal women suffering from the genitourinary syndrome of menopause (GSM). This study was performed on an outpatient basis without anesthesia or drug use before or after the intervention, using an erbium laser (XS Fotona Smooth®, Fotona, Ljubljana, Slovenia) in 1081 postmenopausal women (age 54.3 ± 3.9 years) treated with up to three laser applications every 30 days. Patients were assessed using the Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale-Revised (FSDS-R). No adverse events were recorded during the study. The FSDS-R scores (n = 554), from basal values of 25.5 ± 3.5, were 11.5 ± 3.0, 10.5 ± 3.5 and 11.5 ± 3.5 at the 4-, 12- and 24-week follow-ups, respectively (p < 0.01 vs. corresponding basal values). Individual FSFI domain scores (n = 569) significantly (p < 0.001) increased after VEL-SMOOTH® treatment and remained significantly higher up to the 24th week after the end of treatment. The total scores, from basal values of 15.5 ± 1.5, were 27.5 ± 2.5, 27.6 ± 2.7and 27.0 ± 3.5 at the 4-, 12- and 24-week follow-ups, respectively (p < 0.01 vs. corresponding basal values). Albeit not randomized, this large, prospective study shows that VEL-SMOOTH® treatment may improve sexual function in postmenopausal women suffering from GSM. SN - 1473-0804 UR - https://www.unboundmedicine.com/medline/citation/33124454/Sexual_function_after_vaginal_erbium_laser:_the_results_of_a_large_multicentric_prospective_study_ L2 - https://www.tandfonline.com/doi/full/10.1080/13697137.2020.1804544 DB - PRIME DP - Unbound Medicine ER -